The Atypical Histone MacroH2A1.2 Interacts with HER-2 Protein in Cancer Cells

Xiufen Li, Jinqiu Kuang, Yi Shen, Martin M. Majer, Chad Nelson, Krishna Parsawar, Karen A. Heichman, Scott K. Kuwada

Journal of Biological Chemistry · 2012 · 41 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

Because HER-2 has been demonstrated in the nuclei of cancer cells, we hypothesized that it might interact with transcription factors that activate ERBB2 transcription. Macrohistone 2A1 ( H2AFY ; mH2A1) was found to interact with HER-2 in cancer cells that overexpress HER-2. Of the two human mH2A1 isoforms, mH2A1.2, but not mH2A1.1, interacted with HER-2 in human cancer cell lines. Overexpression of mH2A1.2, but not mH2A1.1, in cancer cells significantly increased HER-2 expression and tumorigenicity. Inhibition of HER-2 kinase activity diminished mH2A1 expression and mH2A1.2-induced ERBB2 transcription in cancer cells. Chromatin immunoprecipitation of mH2A1.2 in cancer cells stably transfected with mH2A1.2 showed enrichment of mH2A1.2 at the HER-2 promoter, suggesting a role for mH2A1.2 in driving HER-2 overexpression. The evolutionarily conserved macro domain of mH2A1.2 was sufficient for the interaction between HER-2 and mH2A1.2 and for mH2A1.2-induced ERBB2 transcription. Within the macro domain of mH2A1.2, a trinucleotide insertion (-EIS-) sequence not found in mH2A1.1 was essential for the interaction between HER-2 and mH2A1.2 as well as mH2A1.2-induced HER-2 expression and cell proliferation. Background: HER-2/c-erbB-2 is commonly overexpressed in cancers, but how its overexpression is achieved is not well understood. Results: HER-2 was found to interact with the atypical histone macroH2A1.2. Conclusion: HER-2 cooperates with macroH2A1.2 to drive HER-2 overexpression in cancer cells. Significance: The discovery of a novel interaction between mH2A1.2 and HER-2 reveals a unique mechanism by which oncogenes can broadly deregulate gene transcription in cancer cells.

References

38